Promega is increasing its production of lab materials used to diagnose the novel coronavirus, which causes the COVID-19 disease, as it continues to spread around the globe.
The company develops reagents and other lab materials for companies across the world, with one of them being Utah-based Co-Diagnostics that developed a test for the virus.
The Co-Diagnostics test, according to the University of Wisconsin-Madison Center for Quick Response Manufacturing, has been approved for testing in Europe and is advancing toward clearance in the U.S. and India.
Promega, which is a partner of the Center for Quick Response Manufacturing, is participating in the manufacturing and dispensing of assay reagents – investigative procedures in laboratory medicine – in less than 10 business days.
According to a blog post written by Promega vice president Chuck York, the company has kept large quantities of lab materials in storage and has since added shifts to produce said materials seven days a week.